William Cook's Cholesterol Plunges on Tower Heart Technology Formula
Louisville, KY - After William Cook suffered two heart attacks and a triple heart by-pass operation he elected natural cholesterol reduction. Doctors monitored Cook's cholesterol and in 8 months it had dropped from 246 to 164 and his LDL cholesterol had dropped from 163 to 101, all on 2 jars of Tower Heart Technology per month, plus 2,000 mg. additional vitamin C as ascorbic acid.
Louisville, KY (PRWEB) February 6, 2004 -- After William Cook suffered two
heart attacks and a triple heart by-pass operation he elected natural
cholesterol reduction. Doctors monitored Cook's cholesterol and in 8 months it
had dropped from 246 to 164 and his LDL cholesterol had dropped from 163 to 101,
all on 2 jars of Tower Heart Technology per month, plus 2,000 mg. additional
vitamin C as ascorbic acid.
All statins - natural or artificial - lower
cholesterol by blocking the same essential enzyme. In 1985 Harwood, et. al.,
made the important discovery that ascorbic acid (Vitamin C) is the human body's
natural HMG-CoA reductase inhibitor, without the liver-destroying potential.
When vitamin C levels are low, the body compensates and manufactures more
cholesterol; when vitamin levels are high, vitamin C inhibits HMG-CoA reductase,
predictably lowering cholesterol.
Cook, declined the artificial statin in
mid-April of 2002 following emergency triple bypass surgery. Instead, he began
Tower Heart Technology after watching a video of Nobelist Linus Pauling
explaining the value of vitamin C for cardiovascular disease. William had his
first heart attack on March 17, 2002 and a second 10 days later on March 27,
2002. In December of 2001 prior to his heart attacks, Bill's numbers had been
Cholesterol 242 and LDL Cholesterol 163.
Cook and long-time friend Sally
Jewell had both worried about their decision, but they became jubilant after the
blood tests results came in, " To our wonderment and surprise, in 8 months his
cholesterol had dropped from 246 to 164 and his LDL cholesterol had dropped from
163 to 101, all on 2 jars of Tower Heart Technology per month, plus 2,000 mg.
additional vitamin C as ascorbic acid."
When the lab report was examined,
William's doctor said, "I've never seen such a drop in cholesterol numbers. If
cardiologists knew this, they would be recommending vitamin C and lysine therapy
to all their patients."
There are several known problems with artificial
statin drugs, such as the popular LipitorÒ or ZocorÒ, which have prompted an
investigation by the National Institutes of Health. These drugs may harm the
liver and increase several cardiovascular risk factors; they reduce circulating
levels of ubiquinone, also know as coenzyme Q10 (CoQ10) and they raise levels of
Lp(a) cholesterol.
The declines in CoQ10 -- attributed to artificial
statins -- have been linked to muscle pain, muscle myopathy and congestive heart
failure. In 2000, researchers at Oxford University linked elevated Lp(a) to the
70 percent higher probability of heart attack or stroke. Warnings to these
effects are carried by Canadian, but not U.S. statin drug
advertisements.
It is known that Vitamin C is required for the body to
synthesize CoQ10, and the vitamin has been shown to decrease circulating levels
of Lp(a). Vitamin C, a primary antioxidant, also protects the liver.
William Cooks before and after lab reports have been scanned and placed
on the Internet. Visit
http://www.internetwks.com/billcook
Harwoods paper is:
Inhibition of HMG-CoA reductase activity by ascorbic acid
HJ Harwood
Jr, YJ Greene and PW Stacpoole
J. Biol. Chem., Vol. 261, Issue 16,
7127-7135, 06, 1986
On the Internet visit:
http://www.jbc.org/cgi/content/abstract/261/16/7127
Information about the Linus Pauling video on Heart Disease is available
at:
http://www.PaulingTherapy.com
Heart Technology is
manufactured in the United States of America by Tower Laboratories Corporation,
Las Vegas, Nevada. Tower Laboratories is an industry leader in the manufacture
and distribution of several popular supplements and high-antioxidant nutritional
drink mixes for sustaining cardiovascular health.
Visit http://www.HeartTechnology.com to learn
more.
CONTACTS:
Sally Jewell, P.O.
Box 21755 Louisville,
KY
40221-0755
(502) 368-2720
Fax: (502) 368-2721
e-mail protected from
spam bots
Owen R. Fonorow,
P O Box 3097
Lisle, IL 60532
800-894-9025
Fax: (630) 416-1309
# # #
Source : http://www.prweb.com/releases/2004/2/prweb102812.htm